Published in Int J Clin Pharmacol Biopharm on August 01, 1979
BOMP/EPI intensive alternating chemotherapy for IGCCC poor-prognosis germ-cell tumors: the Spanish Germ-Cell Cancer Group experience (GG) Ann Oncol (1999) 1.62
Weekly docetaxel in breast cancer: applying clinical data to patient therapy. Oncologist (2001) 1.42
Pharmacokinetics of cefmetazole administered intramuscularly and intravenously to healthy adults. Antimicrob Agents Chemother (1985) 1.10
Concentrations of cefmetazole in plasma and tissue resulting from peri-incisional administration before appendectomy. Antimicrob Agents Chemother (1984) 1.02
Tumor markers at the time of recurrence in patients with germ cell tumors. Cancer (2000) 1.00
Population pharmacokinetics of amikacin in patients with haematological malignancies. J Antimicrob Chemother (1999) 0.94
The influence of uremia on the accessibility of phosphomycin into interstitial tissue fluid. Eur J Clin Pharmacol (1983) 0.92
Randomized trial of neoadjuvant cisplatin and fluorouracil versus carboplatin and fluorouracil in patients with stage IV-M0 head and neck cancer. J Clin Oncol (1995) 0.90
Time-dependent pharmacokinetics of cyclosporine (Neoral) in de novo renal transplant patients. J Clin Pharm Ther (2005) 0.90
Growing teratoma syndrome: experience of a single institution. Eur Urol (1997) 0.90
High-performance liquid chromatographic validated assay of doxorubicin in rat plasma and tissues. J Chromatogr B Biomed Sci Appl (1999) 0.87
Different hCG assays to measure ectopic hCG secretion in bladder carcinoma patients. Br J Cancer (1996) 0.87
Monitoring of serum levels of imipramine and desipramine and individualization of dose in enuretic children. Ther Drug Monit (1984) 0.86
Influence of dosage form and administration route on the pharmacokinetic parameters of cefadroxil. Int J Clin Pharmacol Ther Toxicol (1982) 0.85
Gemcitabine/paclitaxel-based three-drug regimens in advanced urothelial cancer. Eur J Cancer (2000) 0.85
Infectious complications in 126 patients treated with high-dose chemotherapy and autologous peripheral blood stem cell transplantation. Bone Marrow Transplant (1999) 0.85
Pharmacokinetics of cefoxitin in patients with normal or impaired renal function. Eur J Clin Pharmacol (1979) 0.84
Pharmacokinetics of cefoxitin in patients undergoing hemodialysis. Int J Clin Pharmacol Biopharm (1979) 0.84
Mediastinal non-seminomatous germ cell tumours (MNSGCT) treated with cisplatin-based combination chemotherapy. Ann Oncol (1997) 0.83
Pharmacokinetics of cephacetrile in patients undergoing haemodialysis. Eur J Clin Pharmacol (1979) 0.82
Pharmacokinetics of cefamandole in patients undergoing hemodialysis. Int J Clin Pharmacol Biopharm (1979) 0.82
Pleural fluid levels of cefoxitin in patients with renal impairment. Int J Clin Pharmacol Ther Toxicol (1986) 0.82
Pharmacokinetics of cefoxitin during haemofiltration. Eur J Clin Pharmacol (1983) 0.82
Population pharmacokinetics of gentamicin in premature infants. Ther Drug Monit (1992) 0.82
Population pharmacokinetics of albendazole in patients with neurocysticercosis. Int J Clin Pharmacol Ther (2009) 0.82
First-in-man phase I trial of two schedules of the novel synthetic tetrahydroisoquinoline alkaloid PM00104 (Zalypsis) in patients with advanced solid tumours. Br J Cancer (2012) 0.81
Disposition of cefoxitin in patients with pleural effusion. Clin Ther (1981) 0.81
Influence of pharmacokinetic model on vancomycin peak concentration targets. Ther Drug Monit (1996) 0.81
Non-skin solid tumors as a cause of morbidity and mortality after liver transplantation. Transplant Proc (2009) 0.81
Kinetics of ketamine and its metabolites in rabbits with normal and impaired renal function. Eur J Drug Metab Pharmacokinet (1985) 0.81
Population pharmacokinetics of caffeine in premature neonates. Eur J Clin Pharmacol (1997) 0.81
Pharmacokinetics of rectal ketamine in children. Br J Anaesth (1989) 0.81
Linearity of the pharmacokinetics of phosphomycin in serum and interstitial tissue fluid in rabbits. Arzneimittelforschung (1986) 0.81
A phase III randomized trial of cyclophosphamide, mitoxantrone, and 5-fluorouracil (CNF) versus cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) in patients with metastatic breast cancer. Breast Cancer Res Treat (1995) 0.80
Influence of dose in the urinary excretion of amikacin. Int J Clin Pharmacol Ther Toxicol (1984) 0.80
Plasma renin activity, plasma aldosterone and distal urinary acidification in diabetics with chronic renal failure. Proc Eur Dial Transplant Assoc Eur Ren Assoc (1985) 0.80
Comparison of methods of carbamazepine dosage, individualization in epileptic patients. J Clin Pharm Ther (1988) 0.79
Population pharmacokinetics of digoxin in pediatric patients. Ther Drug Monit (2002) 0.79
Disposition of cefoxitin in the elderly. Int J Clin Pharmacol Ther Toxicol (1980) 0.79
[A 48-year-old male with renal infarction and thrombophilia]. Nefrologia (2008) 0.79
Influence of dose on the pharmacokinetics of cefadroxil. Eur J Clin Pharmacol (1980) 0.79
Phase II study of estramustine and vinorelbine in hormone-refractory prostate carcinoma patients. Acta Oncol (1998) 0.78
Disposition of cefoxitin in patients with ascites. Eur J Clin Pharmacol (1981) 0.78
Non-linear tissue binding of amikacin in rats: the effect of renal impairment. Eur J Drug Metab Pharmacokinet (1988) 0.77
Pharmacokinetics of amikacin in intensive care unit patients. J Clin Pharm Ther (1996) 0.77
Modification in the pharmacokinetics of amikacin during development. Eur J Clin Pharmacol (1982) 0.77
Digoxin pharmacokinetics in patients with high serum digoxin concentrations. J Clin Pharm Ther (1993) 0.77
Predictive performance of two phenytoin pharmacokinetic dosing programs from nonsteady state data. Ther Drug Monit (1994) 0.77
Bayesian forecasting in paediatric populations. Clin Pharmacokinet (1996) 0.77
Antigen phenotype and cytotoxic activity of natural killer cells in hemodialysis patients. Am J Kidney Dis (1996) 0.76
Individualization of theophylline dosage in adults with bronchial asthma. Drug Intell Clin Pharm (1986) 0.76
The pharmacokinetics of cefadroxil associated with probenecid. Int J Clin Pharmacol Ther Toxicol (1981) 0.76
Pharmacokinetics of amikacin in children with normal and impaired renal function. Kidney Int (1981) 0.76
[Interferon-alpha and its deleterious effects on kidney transplant: regarding one case]. Nefrologia (2009) 0.76
Haemodiafiltration with sorbent-regenerated ultrafiltrate as replacement fluid: a multicenter study. Nephrol Dial Transplant (1997) 0.76
Pharmacokinetics of cefazolin administered as a new drug delivery system in healthy volunteers. Biopharm Drug Dispos (1989) 0.76
[Multicenter study of darbepoetin alfa in the treatment of anemia secondary to chronic renal insufficiency on dialysis]. Nefrologia (2003) 0.76
The biotransformation kinetics of ketamine "in vitro" in rabbit liver and lung microsome fractions. Eur J Drug Metab Pharmacokinet (1986) 0.76
Urinary prostaglandins (PGE2 and PGI2) in hyporeninaemic hypoaldosteronism in diabetic patients with chronic renal failure. Nephrol Dial Transplant (1994) 0.76
False elevations of alpha-fetoprotein associated with liver dysfunction in germ cell tumors. Cancer (1993) 0.76
Effect of experimentally induced renal impairment on the pharmacokinetics of cefadroxil in rabbits. Arzneimittelforschung (1981) 0.75
Renal management of sodium under indomethacin and aldosterone in the elderly. Age Ageing (1980) 0.75
The influence of ascites on the pharmacokinetics of amikacin. Int J Clin Pharmacol Ther Toxicol (1980) 0.75
Autonomic nervous system in haemodialysis. Nephrol Dial Transplant (1988) 0.75
Pharmacokinetics of phosphomycin during haemofiltration. Br J Clin Pharmacol (1984) 0.75
Population pharmacokinetics of high dose ibuprofen in cystic fibrosis. Arch Dis Child (2003) 0.75
Phosphomycin levels in serum and interstitial tissue fluid in a multiple dosage regimen in rabbits. Arzneimittelforschung (1987) 0.75
[C-reactive protein, acute or intermediate phase reactant in peritoneal dialysis patients with peritonitis?]. Nefrologia (2007) 0.75
[CEA, tumor marker of questioned utility in hemodialysis: report of a case]. Nefrologia (2007) 0.75
Pharmacokinetics of cefotiam during hemofiltration. Int J Clin Pharmacol Ther Toxicol (1986) 0.75
Focal segmental glomerular sclerosis in three generations of a single family. Int J Pediatr Nephrol (1985) 0.75
[Late-onset hemothorax after left jugular vein catheterization for hemodialysis]. Nefrologia (2008) 0.75
[Studies of the correlation between the glycolytic enzymes and general red-cell parameters in the erythrocytes in chronic renal failure (author's transl)]. Sangre (Barc) (1980) 0.75
[Acute polymyositis and acute renal failure]. Rev Clin Esp (1985) 0.75
[Intestinal absorption of vitamin B 12 in renal insufficiency]. Rev Clin Esp (1980) 0.75
Ceforanide pharmacokinetics in haemodialysis: the effect of ultrafiltration. Biopharm Drug Dispos (1986) 0.75
[High dose chemotherapy in germinal testicular tumors]. Med Clin (Barc) (1999) 0.75
[An infrequent cause of hypertriglyceridemia in kidney transplantation]. Nefrologia (2008) 0.75